Low-dose trimethoprim-sulfamethoxazole treatment for pneumocystis pneumonia in non-human immunodeficiency virus-infected immunocompromised patients: A single-center retrospective observational cohort study
ConclusionLow-dose TMP-SMX may be a treatment option for patients with non-HIV PCP.
Source: Journal of Microbiology, Immunology and Infection - Category: Microbiology Source Type: research
More News: Allergy & Immunology | Bactrim | Microbiology | Pneumonia | Study | Sulfamethoxazole | Trimethoprim